NEUROCRINE BIOSCIENCES INC Earnings Per Share (Diluted)
NEUROCRINE BIOSCIENCES INC (NBIX) reported Earnings Per Share (Diluted) of $1.39 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-31
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for the quarter ending 2026-06-30 was $1.39, a 31.13% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for the quarter ending 2026-03-31 was $1.91, a 2287.50% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for the quarter ending 2025-12-31 was $1.48, a 47.36% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for the quarter ending 2025-09-30 was $2.04, a 64.52% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for fiscal 2025 was $4.67, a 41.95% increase from fiscal 2024.
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for fiscal 2024 was $3.29, a 33.20% increase from fiscal 2023.
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for fiscal 2023 was $2.47, a 58.33% increase from fiscal 2022.
- NEUROCRINE BIOSCIENCES INC earnings per share, diluted for fiscal 2022 was $1.56, a 69.57% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.39 10-Q · filed 2026-07-31 | $3.30 10-Q · filed 2026-07-31 | $4.78 derived: net income ÷ weighted average shares · filed 2026-07-31 | $6.81 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2026-03-31 | $1.91 10-Q · filed 2026-05-05 | $3.39 derived: net income ÷ weighted average shares · filed 2026-05-05 | $5.43 derived: net income ÷ weighted average shares · filed 2026-05-05 | $6.51 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2025-12-31 | $1.48 derived: net income ÷ weighted average shares · filed 2026-02-11 | $3.52 derived: net income ÷ weighted average shares · filed 2026-02-11 | $4.59 derived: net income ÷ weighted average shares · filed 2026-07-31 | $4.67 10-K · filed 2026-02-11 |
| 2025-09-30 | $2.04 10-Q · filed 2025-10-28 | $3.12 derived: net income ÷ weighted average shares · filed 2026-07-31 | $3.19 10-Q · filed 2025-10-28 | $4.19 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2025-06-30 | $1.06 10-Q · filed 2026-07-31 | $1.13 10-Q · filed 2026-07-31 | $2.14 derived: net income ÷ weighted average shares · filed 2026-07-31 | $3.39 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2025-03-31 | $0.08 10-Q · filed 2026-05-05 | $1.08 derived: net income ÷ weighted average shares · filed 2026-05-05 | $2.33 derived: net income ÷ weighted average shares · filed 2026-05-05 | $2.96 derived: net income ÷ weighted average shares · filed 2026-05-05 |
| 2024-12-31 | $1.00 derived: net income ÷ weighted average shares · filed 2026-02-11 | $2.25 derived: net income ÷ weighted average shares · filed 2026-02-11 | $2.87 derived: net income ÷ weighted average shares · filed 2026-02-11 | $3.29 10-K · filed 2026-02-11 |
| 2024-09-30 | $1.24 10-Q · filed 2025-10-28 | $1.87 derived: net income ÷ weighted average shares · filed 2025-10-28 | $2.29 10-Q · filed 2025-10-28 | $3.73 derived: net income ÷ weighted average shares · filed 2026-02-11 |
| 2024-06-30 | $0.63 10-Q · filed 2025-07-30 | $1.04 10-Q · filed 2025-07-30 | $2.48 derived: net income ÷ weighted average shares · filed 2026-02-11 | $3.30 derived: net income ÷ weighted average shares · filed 2026-02-11 |
| 2024-03-31 | $0.42 10-Q · filed 2025-05-05 | $1.86 derived: net income ÷ weighted average shares · filed 2026-02-11 | $2.68 derived: net income ÷ weighted average shares · filed 2026-02-11 | $3.63 derived: net income ÷ weighted average shares · filed 2026-02-11 |
| 2023-12-31 | $1.45 derived: net income ÷ weighted average shares · filed 2026-02-11 | $2.27 derived: net income ÷ weighted average shares · filed 2026-02-11 | $3.23 derived: net income ÷ weighted average shares · filed 2026-02-11 | $2.47 10-K · filed 2026-02-11 |
| 2023-09-30 | $0.82 10-Q · filed 2024-10-30 | $1.77 derived: net income ÷ weighted average shares · filed 2024-10-30 | $1.01 10-Q · filed 2024-10-30 | $1.91 derived: net income ÷ weighted average shares · filed 2025-02-10 |
| 2023-06-30 | $0.95 10-Q · filed 2024-08-01 | $0.19 10-Q · filed 2024-08-01 | $1.09 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.78 derived: net income ÷ weighted average shares · filed 2025-02-10 |
| 2023-03-31 | -$0.79 10-Q · filed 2024-05-01 | $0.13 derived: net income ÷ weighted average shares · filed 2025-02-10 | $0.82 derived: net income ÷ weighted average shares · filed 2025-02-10 | $0.65 derived: net income ÷ weighted average shares · filed 2025-02-10 |
| 2022-12-31 | $0.88 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.58 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.43 derived: net income ÷ weighted average shares · filed 2025-02-10 | $1.56 10-K · filed 2025-02-10 |
| 2022-09-30 | $0.69 10-Q · filed 2023-10-31 | $0.53 derived: net income ÷ weighted average shares · filed 2023-10-31 | $0.67 10-Q · filed 2023-10-31 | $0.60 derived: net income ÷ weighted average shares · filed 2024-02-09 |
| 2022-06-30 | -$0.18 10-Q · filed 2023-08-01 | -$0.03 10-Q · filed 2023-08-01 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-02-09 | $0.13 derived: net income ÷ weighted average shares · filed 2024-02-09 |
| 2022-03-31 | $0.14 10-Q · filed 2023-05-03 | $0.07 derived: net income ÷ weighted average shares · filed 2024-02-09 | $0.30 derived: net income ÷ weighted average shares · filed 2024-02-09 | $0.73 derived: net income ÷ weighted average shares · filed 2024-02-09 |
| 2021-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-02-09 | $0.16 derived: net income ÷ weighted average shares · filed 2024-02-09 | $0.59 derived: net income ÷ weighted average shares · filed 2024-02-09 | $0.92 10-K · filed 2024-02-09 |
| 2021-09-30 | $0.23 10-Q · filed 2022-11-01 | $0.66 derived: net income ÷ weighted average shares · filed 2022-11-01 | $0.99 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $0.43 10-Q · filed 2022-08-04 | $0.76 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $0.33 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $3.58 10-K · filed 2021-02-05 | $4.16 10-K · filed 2023-02-09 | ||
| 2020-09-30 | -$0.62 10-Q · filed 2021-11-01 | $0.61 10-Q · filed 2021-11-01 | ||
| 2020-06-30 | $0.81 10-Q · filed 2021-08-03 | $1.20 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $0.39 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $0.35 10-K · filed 2021-02-05 | $0.39 10-K · filed 2022-02-11 | ||
| 2019-09-30 | $0.56 10-K · filed 2021-02-05 | $0.03 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $0.54 10-K · filed 2021-02-05 | -$0.56 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | -$1.12 10-K · filed 2021-02-05 | |||
| 2018-12-31 | $0.19 10-K · filed 2020-02-07 | $0.22 10-K · filed 2021-02-05 | ||
| 2018-09-30 | $0.52 10-K · filed 2020-02-07 | $0.03 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | -$0.07 10-K · filed 2020-02-07 | -$0.53 10-Q · filed 2019-07-29 | ||
| 2018-03-31 | -$0.47 10-K · filed 2020-02-07 | |||
| 2017-12-31 | $0.07 10-K · filed 2019-02-08 | -$1.62 10-K · filed 2020-02-07 | ||
| 2017-09-30 | -$0.13 10-K · filed 2019-02-08 | -$1.70 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | -$0.68 10-K · filed 2019-02-08 | |||
| 2017-03-31 | -$0.90 10-K · filed 2019-02-08 | |||
| 2016-12-31 | -$1.63 10-K · filed 2019-02-08 | |||
| 2015-12-31 | -$1.05 10-K · filed 2018-02-13 | |||
| 2014-12-31 | -$0.81 10-K · filed 2017-02-14 | |||
| 2013-12-31 | -$0.16 10-K · filed 2014-02-11 | -$0.69 10-K · filed 2016-02-11 | ||
| 2013-09-30 | -$0.17 10-K · filed 2014-02-11 | |||
| 2013-06-30 | -$0.18 10-K · filed 2014-02-11 | |||
| 2013-03-31 | -$0.18 10-K · filed 2014-02-11 | |||
| 2012-12-31 | $0.14 10-K · filed 2014-02-11 | $0.08 10-K · filed 2015-02-09 | ||
| 2012-09-30 | -$0.05 10-K · filed 2014-02-11 | -$0.07 10-Q · filed 2012-10-31 | ||
| 2012-06-30 | -$0.01 10-K · filed 2014-02-11 | -$0.02 10-Q · filed 2012-07-31 | ||
| 2012-03-31 | -$0.01 10-K · filed 2014-02-11 | |||
| 2011-12-31 | $0.02 10-K · filed 2013-02-08 | $0.67 10-K · filed 2014-02-11 | ||
| 2011-09-30 | $0.56 10-K · filed 2013-02-08 | $0.64 10-Q · filed 2012-10-31 | ||
| 2011-06-30 | $0.04 10-K · filed 2013-02-08 | $0.09 10-Q · filed 2012-07-31 | ||
| 2011-03-31 | $0.05 10-K · filed 2013-02-08 | |||
| 2010-12-31 | -$0.15 10-K · filed 2013-02-08 | |||
| 2010-09-30 | $0.06 10-Q · filed 2011-10-31 | -$0.20 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$0.09 10-Q · filed 2011-07-29 | -$0.27 10-Q · filed 2011-07-29 | ||
| 2009-12-31 | -$1.30 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |